Strongbridge Biopharma plc - Ordinary Shares (SBBP): Price and Financial Metrics


Strongbridge Biopharma plc - Ordinary Shares (SBBP): $2.86

-0.04 (-1.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SBBP POWR Grades


  • SBBP scores best on the Value dimension, with a Value rank ahead of 77.23% of US stocks.
  • The strongest trend for SBBP is in Momentum, which has been heading down over the past 31 weeks.
  • SBBP ranks lowest in Momentum; there it ranks in the 5th percentile.

SBBP Stock Summary

  • SBBP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 352.72 -- higher than 89.61% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of 139.19%, Strongbridge Biopharma plc's debt growth rate surpasses 92.89% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for SBBP comes in at -24.54% -- higher than that of merely 10.42% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Strongbridge Biopharma plc are FLDM, MYSZ, ONCT, CRIS, and WISA.
  • Visit SBBP's SEC page to see the company's official filings. To visit the company's web site, go to www.strongbridgebio.com.

SBBP Price Target

For more insight on analysts targets of SBBP, see our SBBP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.83 Average Broker Recommendation 1.42 (Moderate Buy)

SBBP Stock Price Chart Interactive Chart >

Price chart for SBBP

SBBP Price/Volume Stats

Current price $2.86 52-week high $4.63
Prev. close $2.90 52-week low $1.87
Day low $2.85 Volume 370,647
Day high $2.96 Avg. volume 1,147,533
50-day MA $2.57 Dividend yield N/A
200-day MA $2.67 Market Cap 193.30M

Strongbridge Biopharma plc - Ordinary Shares (SBBP) Company Bio


Strongbridge Biopharma PLC is focused on the development, in-licensing, acquisition and eventual commercialization of complementary product candidates across multiple franchises that target rare diseases. The company was founded in 1996 and is based in Trevose, Pennsylvania.


SBBP Latest News Stream


Event/Time News Detail
Loading, please wait...

SBBP Latest Social Stream


Loading social stream, please wait...

View Full SBBP Social Stream

Latest SBBP News From Around the Web

Below are the latest news stories about Strongbridge Biopharma plc that investors may wish to consider to help them evaluate SBBP as an investment opportunity.

SHAREHOLDER ALERT: WeissLaw LLP Reminds SNX, MMAC, SBBP, and HRVSF Shareholders About Its Ongoing Investigations

NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212) 682-3025(888) [email protected] SYNNEX Corporation (NYSE: SNX) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board o

Yahoo | June 15, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ARPO, ALTA, MMAC, SBBP; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Aadi Bioscience, Inc. Under the merger, Aadi shareholders will receive newly issued shares of Aerpio common stock. On a pro forma basis, Aerpio shareholders will own approximate

Yahoo | June 8, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds MMAC, SBBP, HRVSF, and XOG Shareholders About Its Ongoing Investigations

NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212) 682-3025(888) [email protected] MMA Capital Holdings, Inc. (NASDAQ: MMAC) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by

Yahoo | June 8, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TGRF, SLCT, ESXB, SBBP, MX; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | June 5, 2021

Lifshitz Law Firm, P.C. Announces Investigation of CLDR, DTRCD, DCRN, ENVB, PACX, SNX, XERS, and SBBP

Cloudera, Inc. (NYSE: CLDR)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CLDR to affiliates of Clayton, Dubilier & Rice and KKR & Co. Inc. for $16.00 in cash per share.

Yahoo | June 4, 2021

Read More 'SBBP' Stories Here

SBBP Price Returns

1-mo 25.44%
3-mo -13.86%
6-mo 9.16%
1-year -19.66%
3-year -58.25%
5-year -29.03%
YTD 17.70%
2020 16.27%
2019 -53.35%
2018 -38.21%
2017 202.08%
2016 -68.42%

Continue Researching SBBP

Here are a few links from around the web to help you further your research on Strongbridge Biopharma plc's stock as an investment opportunity:

Strongbridge Biopharma plc (SBBP) Stock Price | Nasdaq
Strongbridge Biopharma plc (SBBP) Stock Quote, History and News - Yahoo Finance
Strongbridge Biopharma plc (SBBP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 2.08 seconds.